Global Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry by Country

In 2023, Switzerland led global pharmaceutical R&D expenditure, with Belgium and Denmark trailing. Emerging economies like China and Mexico showed lower positions. Asian countries such as South Korea, Taiwan, and Israel, despite strong technology sectors, ranked lower in this data set. Year-on-year variation was negligible, maintaining stability in R&D expenditure distribution. The five-year CAGR suggests consistency, indicating no significant growth or decline enters the scene for these nations.

Future trends to monitor include potential R&D investment shifts in emerging markets like China and Mexico and increased digitalization impacting pharmaceutical research processes globally. Collaborative R&D engagements across borders could also drive expenditure changes.